Logo image of RAK.CA

RACKLA METALS INC (RAK.CA) Stock Fundamental Analysis

TSX-V:RAK - TSX Venture Exchange - CA7500802029 - Common Stock - Currency: CAD

0.265  -0.01 (-1.85%)

Fundamental Rating

2

RAK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 802 industry peers in the Metals & Mining industry. RAK has a great financial health rating, but its profitability evaluates not so good. RAK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RAK had negative earnings in the past year.
In the past year RAK has reported a negative cash flow from operations.
In the past 5 years RAK always reported negative net income.
RAK had a negative operating cash flow in each of the past 5 years.
RAK.CA Yearly Net Income VS EBIT VS OCF VS FCFRAK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

With a Return On Assets value of -90.43%, RAK is not doing good in the industry: 72.82% of the companies in the same industry are doing better.
RAK has a Return On Equity of -107.68%. This is in the lower half of the industry: RAK underperforms 65.84% of its industry peers.
Industry RankSector Rank
ROA -90.43%
ROE -107.68%
ROIC N/A
ROA(3y)-76.93%
ROA(5y)-155.06%
ROE(3y)-96.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RAK.CA Yearly ROA, ROE, ROICRAK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K 4K 5K

1.3 Margins

RAK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RAK.CA Yearly Profit, Operating, Gross MarginsRAK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, RAK has more shares outstanding
The number of shares outstanding for RAK has been increased compared to 5 years ago.
RAK has a worse debt/assets ratio than last year.
RAK.CA Yearly Shares OutstandingRAK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
RAK.CA Yearly Total Debt VS Total AssetsRAK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M

2.2 Solvency

An Altman-Z score of 19.07 indicates that RAK is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 19.07, RAK belongs to the top of the industry, outperforming 81.30% of the companies in the same industry.
RAK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.07
ROIC/WACCN/A
WACCN/A
RAK.CA Yearly LT Debt VS Equity VS FCFRAK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 4.47 indicates that RAK has no problem at all paying its short term obligations.
The Current ratio of RAK (4.47) is better than 74.69% of its industry peers.
RAK has a Quick Ratio of 4.47. This indicates that RAK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.47, RAK is in the better half of the industry, outperforming 75.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.47
Quick Ratio 4.47
RAK.CA Yearly Current Assets VS Current LiabilitesRAK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

RAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.97%, which is quite impressive.
EPS 1Y (TTM)39.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RAK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RAK.CA Price Earnings VS Forward Price EarningsRAK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RAK.CA Per share dataRAK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RAK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RACKLA METALS INC

TSX-V:RAK (5/9/2025, 7:00:00 PM)

0.265

-0.01 (-1.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.26%
Inst Owner ChangeN/A
Ins Owners32.26%
Ins Owner ChangeN/A
Market Cap28.50M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.67
P/tB 8.67
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -90.43%
ROE -107.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-76.93%
ROA(5y)-155.06%
ROE(3y)-96.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 849.58%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.47
Quick Ratio 4.47
Altman-Z 19.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-791.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-837.14%
OCF growth 3YN/A
OCF growth 5YN/A